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Successful re-exposure to clozapine after eosinophilia 
and clinically suspected myocarditis 
Letter to the Editors
Dear Editor,
Clozapine is a highly effective antipsychotic drug, but it is 
DVVRFLDWHGZLWKVLJQLÀFDQWDGYHUVHUHDFWLRQV:HDUHUHSRUW-
ing a case of successful re-challenge with clozapine after 
HRVLQRSKLOLDDQGFOLQLFDOO\VXVSHFWHGP\RFDUGLWLV
Clinical Case
The patient is a 22-year-old gentleman with a 3-year history 
RISDUDQRLGVFKL]RSKUHQLDDQGSRRUUHVSRQVHWRWUHDWPHQW
:LWKDQRUPDOZKLWHEORRGFHOOFRXQWDEVROXWHQHXWURSKLO
count (ANC) and absolute eosinophil count (AEC), we initi-
DWHG FOR]DSLQH WUHDWPHQW DW PJ WZLFHSHU GD\$IWHU
14 days of increasing treatment, the eosinophil count 
was elevated at 820/μL, and the patient reported shortness 
RIEUHDWKDQGWDFK\FDUGLD2QGD\WKHVHGLPHQWDWLRQ
rate (SR) and C-Reactive Protein (CRP) were increased 
PPKDQGPJ/7KHFKHVW[UD\ZDVQRUPDOWKH




the patient reported chest pain and had elevated SR and 
&53SHDNDW7KHFRPSXWHGWRPRJUDSK\DQJLRJUDSK\
showed mild left lower lobe atelectasis and small pleural 
HIIXVLRQEXWQRLVFKHPLDSHULFDUGLWLVRUP\RFDUGLWLV$(&
VWDELOL]HGDWDSSUR[LPDWHO\õ/(LJKWHHQGD\VDIWHU





IRUP\RFDUGLDO LQYROYHPHQW LQ SDWLHQWV WDNLQJ FOR]DSLQH
HVSHFLDOO\LQWKHSUHVHQFHRIHRVLQRSKLOLD(RVLQRSKLOLDDV-
sociated with clozapine has been reported in 1 to 62%1,2 of 
SDWLHQWVZKRRIWHQUHPDLQDV\PSWRPDWLF,QLWLDOV\PSWRPV
RI FOR]DSLQHLQGXFHGP\RFDUGLWLV DUH XQVSHFLÀF RU HYHQ
DEVHQW1 Eosinophilia was found in 65% of clozapine-induced 
P\RFDUGLWLVFDVHVDQGRISDWLHQWVZLWKRXWP\RFDUGLWLV
Some have reported tachycardia in up to 90% of myocar-
GLWLV FDVHV4 5RQDOGVRQ HW DO UHFRPPHQG WKH IROORZLQJ 
JXLGHOLQHV IRU WKH HDUO\ GHWHFWLRQ RIP\RFDUGLWLV EDVH-
line troponins, CRP, echocardiogram and monitoring for 
ZHHNV FRQWLQXHG WUHDWPHQW IRUPLOGP\RFDUGLWLV DQG
GHÀQLQJ WKUHVKROGV IRU GLVFRQWLQXDWLRQ3 Eosinophilia was 
QRWLQFOXGHGLQWKHSURWRFRO2WKHUDXWKRUV5 recommend an 
HOHFWURFDUGLRJUDPVHUXPWURSRQLQVRU&.0%P\RFDUGLDO
band) for patients who develop fever, cardiorespiratory and 
ÁXOLNHV\PSWRPVRUHRVLQRSKLOLDZKLOHRQFOR]DSLQH,QWKH
absence of a standardized protocol or an effective screening 
assay for clozapine-induced myocarditis, close monitoring is 
UHFRPPHQGHGHVSHFLDOO\LQWKHÀUVWZHHNVRIWUHDWPHQW
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